Global RSV Diagnostics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global RSV Diagnostics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Respiratory Syncytial Virus (RSV) diagnostics refer to the various methods and tests used to detect and diagnose RSV infections. These diagnostics play a crucial role in identifying and managing RSV infections, especially in infants and young children who are more susceptible to severe respiratory illness caused by the virus.
RSV Diagnostics report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global RSV Diagnostics market is projected to reach US$ 1331 million in 2033, increasing from US$ 743.5 million in 2022, with the CAGR of 8.7% during the period of 2023 to 2033. Demand from Hospitals & Clinics and Clinical Laboratories are the major drivers for the industry.
The RSV diagnostics market has been experiencing significant growth due to the high prevalence of RSV infections, especially among infants and young children. The market is driven by factors such as increasing awareness about RSV infections, advancements in diagnostic technologies, and the growing need for accurate and rapid diagnosis.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global RSV Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
BioMérieux
Abbott
Roche
BD
Thermo Fisher
Luminex
Danaher
Biocartis
Hologic
Segment by Type
Kits and Assays
Instruments
Other
Hospitals & Clinics
Clinical Laboratories
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the RSV Diagnostics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, RSV Diagnostics introduction, etc. RSV Diagnostics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of RSV Diagnostics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
RSV Diagnostics report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global RSV Diagnostics market is projected to reach US$ 1331 million in 2033, increasing from US$ 743.5 million in 2022, with the CAGR of 8.7% during the period of 2023 to 2033. Demand from Hospitals & Clinics and Clinical Laboratories are the major drivers for the industry.
The RSV diagnostics market has been experiencing significant growth due to the high prevalence of RSV infections, especially among infants and young children. The market is driven by factors such as increasing awareness about RSV infections, advancements in diagnostic technologies, and the growing need for accurate and rapid diagnosis.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global RSV Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
BioMérieux
Abbott
Roche
BD
Thermo Fisher
Luminex
Danaher
Biocartis
Hologic
Segment by Type
Kits and Assays
Instruments
Other
Segment by Application
Hospitals & Clinics
Clinical Laboratories
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the RSV Diagnostics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, RSV Diagnostics introduction, etc. RSV Diagnostics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of RSV Diagnostics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.